↓ Skip to main content

Health-related quality of life in patients receiving first-line eribulin mesylate with or without trastuzumab for locally recurrent or metastatic breast cancer

Overview of attention for article published in BMC Cancer, June 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

peer_reviews
1 peer review site

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
88 Mendeley
Title
Health-related quality of life in patients receiving first-line eribulin mesylate with or without trastuzumab for locally recurrent or metastatic breast cancer
Published in
BMC Cancer, June 2019
DOI 10.1186/s12885-019-5674-5
Pubmed ID
Authors

Lee Schwartzberg, Kristi McIntyre, Sharon Wilks, Shannon Puhalla, Joyce O’Shaughnessy, Erhan Berrak, Yaohua He, Linda Vahdat

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 88 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 88 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 10 11%
Researcher 8 9%
Student > Master 7 8%
Lecturer 5 6%
Student > Ph. D. Student 4 5%
Other 7 8%
Unknown 47 53%
Readers by discipline Count As %
Medicine and Dentistry 12 14%
Nursing and Health Professions 11 13%
Pharmacology, Toxicology and Pharmaceutical Science 4 5%
Biochemistry, Genetics and Molecular Biology 3 3%
Agricultural and Biological Sciences 2 2%
Other 8 9%
Unknown 48 55%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 June 2019.
All research outputs
#15,575,425
of 23,150,406 outputs
Outputs from BMC Cancer
#4,171
of 8,403 outputs
Outputs of similar age
#217,432
of 353,827 outputs
Outputs of similar age from BMC Cancer
#117
of 207 outputs
Altmetric has tracked 23,150,406 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,403 research outputs from this source. They receive a mean Attention Score of 4.3. This one is in the 40th percentile – i.e., 40% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 353,827 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 207 others from the same source and published within six weeks on either side of this one. This one is in the 33rd percentile – i.e., 33% of its contemporaries scored the same or lower than it.